NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 22 filers reported holding NOVABAY PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,000 | -55.3% | 195,576 | +3.4% | 0.00% | – |
| Q2 2022 | $47,000 | +9.3% | 189,124 | +28.4% | 0.00% | – |
| Q1 2022 | $43,000 | -21.8% | 147,318 | 0.0% | 0.00% | – |
| Q4 2021 | $55,000 | -41.5% | 147,318 | 0.0% | 0.00% | – |
| Q3 2021 | $94,000 | -4.1% | 147,318 | 0.0% | 0.00% | – |
| Q2 2021 | $98,000 | -26.9% | 147,318 | 0.0% | 0.00% | – |
| Q1 2021 | $134,000 | +173.5% | 147,318 | +109.1% | 0.00% | – |
| Q4 2020 | $49,000 | -3.9% | 70,444 | 0.0% | 0.00% | – |
| Q3 2020 | $51,000 | -37.0% | 70,444 | 0.0% | 0.00% | – |
| Q2 2020 | $81,000 | +1250.0% | 70,444 | +579.2% | 0.00% | – |
| Q1 2020 | $6,000 | -50.0% | 10,371 | -50.0% | 0.00% | – |
| Q4 2019 | $12,000 | +100.0% | 20,742 | +100.0% | 0.00% | – |
| Q3 2019 | $6,000 | -64.7% | 10,371 | 0.0% | 0.00% | – |
| Q2 2019 | $17,000 | – | 10,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 52,301 | $36,000 | 0.00% |
| TOWNSQUARE CAPITAL LLC | 53,672 | $37,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 17,500 | $12,000 | 0.00% |
| NVWM, LLC | 2,997 | $2,000 | 0.00% |
| Advisory Services Network, LLC | 20,500 | $14,000 | 0.00% |
| VANGUARD GROUP INC | 160,224 | $112,000 | 0.00% |
| UBS Group AG | 10,353 | $7,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 25,000 | $17,000 | 0.00% |
| Sugarloaf Wealth Management, LLC | 2,000 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 3,260 | $3,000 | 0.00% |